Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 21, 2020; 26(27): 3952-3962
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3952
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3952
Variable | Training group (n = 138) | Validation group (n = 137) | ||||
F ≥ 2 | F ≥ 3 | F = 4 | F ≥ 2 | F ≥ 3 | F = 4 | |
AUC | 0.842 | 0.920 | 0.904 | 0.805 | 0.886 | 0.863 |
95%CI | 0.777-0.907 | 0.872-0.967 | 0.842-0.955 | 0.733-0.877 | 0.827-0.946 | 0.784-0.943 |
Cut-off | 0.0304 | 0.496 | 0.553 | 0.174 | 0.176 | 0.206 |
Sensitivity, % | 81.1 | 90.9 | 96.2 | 72.4 | 89.1 | 97.1 |
Specificity | 71.9 | 78.7 | 71.4 | 80.3 | 72.5 | 70.6 |
Youden’s index | 0.530 | 0.696 | 0.676 | 0.527 | 0.616 | 0.677 |
PPV | 76.9 | 66.7 | 43.9 | 82.1 | 62.1 | 53.1 |
NPV | 76.7 | 94.9 | 98.8 | 70.0 | 93.0 | 98.6 |
- Citation: Kang NL, Zhang JM, Lin MX, Chen XD, Huang ZX, Zhu YY, Liu YR, Zeng DW. Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients. World J Gastroenterol 2020; 26(27): 3952-3962
- URL: https://www.wjgnet.com/1007-9327/full/v26/i27/3952.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i27.3952